Researchers have identified a compound that prevents damage to the retina caused by diabetic retinopathy. The drug works by interrupting the chain of events that cause vision loss in people suffering from diabetic retinopathy. The finding by University of Michigan Kellogg Eye Center is significant because it could lead to a novel therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects ...
via Medindia Health News More READ
No comments:
Post a Comment